Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
马鹿骨骨碎补胶囊 (Malu Gu Gusuibu Capsule) is an oral health supplement developed and manufactured by Jilin Fukang Pharmaceutical. It is formulated with red deer bone (Cervus elaphus) and the rhizome of Drynaria fortunei (Gusuibu), a traditional Chinese medicinal herb. The product is primarily indicated for increasing bone mineral density and supporting overall bone health. Red deer bone serves as a natural source of calcium, phosphorus, and collagen, while Drynaria fortunei contains bioactive compounds such as flavonoids (e.g., naringin) that are traditionally associated with bone healing and strengthening. It is registered as a health food product (Blue Hat) in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 马鹿骨骨碎补胶囊.